A Study Of Genetic And Clinical Correlation In Ehlers Danlos Syndrome

Overview

About this study

The purpose of this study is to to deeply phenotype individuals carrying genetic variants in an EDS-associated gene.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Participating probands must be 18 years or older and have had genetic testing with the identification of a genetic variant.

  • Participating family members of probands must be 18 years or older.

 

Exclusion Criteria:

  • Individuals under the age of 18 years.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

 

Eligibility last updated 01/11/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Linnea Baudhuin

Open for enrollment

Contact information:

DLMP Research and Innovation Office

(507) 284-9080

DLMPRIO@mayo.edu

More information

Publications

Publications are currently not available